Gary B. Gordon, Director at TriSalus Life Sciences, Inc. (TLSI), bought 9,756 shares at $4.10 ($40K) on 2026-02-23, disclosed to the SEC on 2026-02-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AYLA | SELL | 2021-01-22 | $45K | — | Filing → |